)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Pharmaids Pharmaceuticals
Pharmaids Pharmaceuticals (524572) investor relations material
Pharmaids Pharmaceuticals Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary12 Aug, 2026
Executive summary
Unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, were approved and published following a board meeting on August 12, 2026.
The group operates in a single segment: Contract Research and Manufacturing Services.
Financial highlights
Standalone revenue from operations for Q1 FY27 was Rs 111.53 lakhs, down from Rs 268.89 lakhs year-over-year and Rs 1,060.25 lakhs sequentially.
Standalone net profit for Q1 FY27 was Rs 61.21 lakhs, compared to a loss of Rs 132.83 lakhs year-over-year.
Consolidated revenue from operations for Q1 FY27 was Rs 412.14 lakhs, down from Rs 2,788.24 lakhs year-over-year.
Consolidated net profit for Q1 FY27 was Rs 187.15 lakhs, compared to a loss of Rs 531.53 lakhs year-over-year.
Basic and diluted EPS for Q1 FY27 were Rs 0.61 (standalone) and Rs 0.63 (consolidated), compared to negative EPS in the prior year.
Outlook and guidance
The company will hold its 37th AGM via video conferencing, with further details to be shared.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Pharmaids Pharmaceuticals
- Revenue increased but net losses persisted; borrowings and cash reserves declined.524572
Q4 25/26 - Quarterly consolidated net loss of Rs. 264.60 lakhs on revenue of Rs. 543 lakhs; lease discontinued.524572Q3 25/26
- Losses narrowed on higher revenue, with major disinvestment and debt repayment completed.524572Q2 25/26
- Q1 FY26 saw higher losses and a pending major divestment, with no impact on current results.524572Q1 25/26
- Q2 and H1 FY25 results reflect ongoing losses and negative cash flows amid sector focus.524572Q2 24/25
- Losses persist despite higher standalone revenue; consolidated revenue declines year-over-year.524572Q1 24/25
- Revenue growth offset by higher losses and increased investments in FY25.524572Q4 24/25
- Revenue up but losses deepen; asset sale and capital moves mark strategic shift.524572Q3 24/25
Next Pharmaids Pharmaceuticals earnings date
Q2 26/2712 Nov, 2026
Pharmaids Pharmaceuticals
Next Pharmaids Pharmaceuticals earnings date
Q2 26/2712 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Pharmaids Pharmaceuticals Limited is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical formulations. The company produces a range of dosage forms including tablets, capsules, and syrups across various therapeutic segments. Its operations primarily cater to the domestic market, with a focus on providing affordable healthcare solutions. Pharmaids Pharmaceuticals Limited may also undertake contract manufacturing activities in support of other pharmaceutical businesses. The company is headquartered in Hyderabad, India, and its shares are listed on the BSE.